1315 Capital


1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $30 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.

M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from 1315 Capital.

In the last 3 years, 1315 Capital has acquired 2 companies. It has also invested in 1 other.

1315 Capital’s most common sectors for investment are life science (43%) and medical products (43%). The Firm’s most common investment types include venture (58%) and divestiture (29%). In total, 1315 Capital has invested in 6 US states.

Join Mergr to view 1315 Capital’s full profile and discover more small private equity firms just like it.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.5K Private Equity Firms
  • 124K M&A Transactions
  • 133K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.